Scientists have identified a compound that can kill the parasites responsible for three neglected diseases: Chagas disease, leishmaniasis and sleeping sickness.
These diseases affect millions of people in Latin America, Asia and Africa, but there are few effective treatments available.
A new study, published today in Nature, suggests that a single class of drugs could be used to treat all three. Wellcome-funded researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a chemical that can cure all of these diseases in mice. It also does not harm human cells in laboratory tests, providing a strong starting point for drug development.
Chagas, leishmaniasis and sleeping sickness have different symptoms, but are all caused by parasites called ‘kinetoplastids’ – a type of single-celled organism. The parasites share similar biology and genetics, which led scientists to think it might be possible to find a single chemical that could destroy all three.
The team at GNF tested over 3 million different chemicals and identified a compound, GNF6702, which was effective against the parasites but did not damage human cells. They refined this starting compound to make it more potent before testing in it mice.
Senior study author Frantisek Supek from GNF said: “We found that these parasites harbour a common weakness. We hope to exploit this weakness to discover and develop a single class of drugs for all three diseases.”
Dr Stephen Caddick, Director of Innovation at Wellcome, said: “These three diseases lead to more than 50,000 deaths annually, yet they receive relatively little funding for research and drug development. We hope that our early stage support for this research will provide a basis for the development of new treatments that could reduce suffering for millions of people in the poorest regions of the world.”
Existing treatments for the three diseases are expensive, often have side effects and are not very effective. The fact that GNF6702 does not seem to have any adverse effects in mice suggests that it might have fewer side-effects than existing drugs, although this will need to be explored in human studies. GNF6702 is now being tested for toxicity before it can be moved in to clinical trials.
The Latest on: GNF6702
via Google News
The Latest on: GNF6702
- Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research on February 11, 2019 at 11:18 pm
It displays unprecedented in vivo efficacy, clearing parasites from mice in all three models of infection. GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not i... […]
- The waste disposal system of parasites: a new target for drugs against neglected tropical diseases on September 22, 2016 at 5:00 pm
cruzi in the lab in the presence of sub lethal doses of the lead compound GNF6702. By slowly increasing the dose given, they were able to select for populations of parasites which had undergone mutati... […]
- Three Diseases at Once? on August 15, 2016 at 5:11 am
A lead compound (GMF5343) was optimized to give GNF6702. Note that the key change was switching out the heterocyclic core; work on the side chains did the rest. GNF3849 looks like a pretty good compou... […]
- Scientists Discover a New Drug That Can Knock Out Three Killer Diseases on August 11, 2016 at 5:00 pm
After millions of tests, the team emerged with one—GNF6702—which they then refined to make its ability to bind the parasite about 20 times more potent. Image Source: Universitat Tubingen The drug has ... […]
- Scientists just made a discovery that could change how we treat diseases that affect 20 million people on August 10, 2016 at 3:11 am
So, the scientists figured out a compound, which they dubbed GNF6702, that might be able to treat all three. Finding one drug that could treat all three could be a major move in getting the treatment ... […]
- Infectious disease: Promising therapeutic target for three parasitic diseases on August 8, 2016 at 5:00 pm
The drug candidate, named GNF6702, performed well in mouse models of the three diseases, where it appears to work by selectively blocking the activity of the parasite proteasome, a tiny structure invo... […]
- Single agent targets three parasitic infections on August 8, 2016 at 12:38 pm
The compound, called GNF6702, can clear the sleeping sickness, leishmaniasis, and Chagas parasites from mice with efficacy comparable to existing anti-kinetoplastid medications. And the molecule does ... […]
- Compound found to treat three parasitic tropical diseases on August 8, 2016 at 8:01 am
They identified a compound, called GNF6702, that worked against the parasites, and then refined it to make it more potent before testing in it mice. "We found that these parasites harbor a common weak... […]
- A single compound could treat three parasitic diseases on August 7, 2016 at 5:00 pm
The team at GNF tested over 3 million different chemicals and identified a compound, GNF6702, which was effective against the parasites but did not damage human cells. They refined this starting compo... […]
via Bing News